Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia

Vaccine

Volumn 32, Issue 41, 2014, Pages 5311-5315

  Jõgi, Piia ^a,b   Oona, Marje ^a   Toompere, Karolin ^a   Leedo, Sirje ^b   Epstein, Jevgenia ^c   Lutsar, Irja ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

^c Tartu University Hospital ^*  (Estonia)

Author keywords

Anti PT IgG; Immunisation; Pertussis incidence; Seroepidemiology; Whooping cough

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; PERTUSSIS VACCINE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTONIA; HUMAN; IMMUNIZATION; INCIDENCE; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; SEROPREVALENCE; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; PREVALENCE; WHOOPING COUGH;

ADOLESCENT; ANTIBODIES, BACTERIAL; CHILD; CROSS-SECTIONAL STUDIES; ESTONIA; HUMANS; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; PERTUSSIS VACCINE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; WHOOPING COUGH;

EID: 84925884129     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.07.066     Document Type: Article

References (26)

1. Crowcroft N.S., Stein C., Duclos P., Birmingham M. How best to estimate the global burden of pertussis?. Lancet Infect Dis 2003, 3(7):413-418.
2. Wiley K.E., Zuo Y., Macartney K.K., McIntyre P.B. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013, 31(4):618-625.
3. Lutsar I., Anca I., Bakir M., Usonis V., Prymula R., Salman N., et al. Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005. Eur J Pediatr 2009, 168(4):407-415.
4. Guiso N., Berbers G., Fry N.K., He Q., Riffelmann M., Wirsing von König C.H., et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011, 30(3):307-312.
5. Celentano L.P., Massari M., Paramatti D., Salmaso S., Tozzi A.E., Group E.-N. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005, 24(9):761-765.
6. Cherry J.D. Epidemiology of pertussis. Pediatr Infect Dis J 2006, 25(4):361-362.
7. Riffelmann M., Thiel K., Schmetz J., Wirsing von Koenig C.H. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 2010, 48(12):4459-4463.
8. Campbell H., Amirthalingam G., Andrews N., Fry N.K., George R.C., Harrison T.G., et al. Accelerating control of pertussis in England and Wales. Emerg Infect Dis 2012, 18(1):38-47.
9. de Melker H.E., Versteegh F.G., Schellekens J.F., Teunis P.F., Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006, 53(2):106-113.
10. Campbell P., McIntyre P., Quinn H., Hueston L., Gilbert G.L., McVernon J. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS ONE 2012, 7(4):e35874.
11. Pebody R.G., Gay N.J., Giammanco A., Baron S., Schellekens J., Tischer A., et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005, 133(1):159-171.
12. Quinn H.E., McIntyre P.B., Backhouse J.L., Gidding H.F., Brotherton J., Gilbert G.L. The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiol Infect 2010, 138(3):426-433.
13. Zhang Q., Zheng H., Liu M., Han K., Shu J., Wu C., et al. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis 2012, 12:138.
14. Socan M., Prosenc K., Vegnuti M. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population. Wien Klin Wochenschr 2006, 118(11-12):336-340.
15. Rendi-Wagner P., Tobias J., Moerman L., Goren S., Bassal R., Green M., et al. The seroepidemiology of Bordetella pertussis in Israel - estimate of incidence of infection. Vaccine 2010, 28(19):3285-3290.
16. Müller F.M., Hoppe J.E., Wirsing von König C.H. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997, 35(10):2435-2443.
17. de Melker H.E., Versteegh F.G., Conyn-Van Spaendonck M.A., Elvers L.H., Berbers G.A., van Der Zee A., et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000, 38(2):800-806.
18. Giammanco A., Chiarini A., Maple P.A., Andrews N., Pebody R., Gay N., et al. European sero-epidemiology network: standardisation of the assay results for pertussis. Vaccine 2003, 22(1):112-120.
19. Storsaeter J., Hallander H.O., Gustafsson L., Olin P. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 2003, 21(25-26):3542-3549.
20. de Greeff S.C., de Melker H.E., van Gageldonk P.G., Schellekens J.F., van der Klis F.R., Mollema L., et al. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS ONE 2010, 5(12):e14183.
21. Cagney M., MacIntyre C.R., McIntyre P., Puech M., Giammanco A. The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiol Infect 2006, 134(6):1208-1216.
22. Immunisation Schedule of Estonia [Internet]. Available from: . https://www.riigiteataja.ee/aktilisa/1070/7201/1003/SOM_01072011_m30_lisa.pdf#.
23. Warfel J.M., Zimmerman L.I., Merkel T.J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014, 111(2):787-792.
24. Zhang Q., Yin Z., Li Y., Luo H., Shao Z., Gao Y., et al. Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: a cross-sectional study. Scand J Infect Dis 2014, 46(4):280-287.
25. Mark A., Granström M. Cumulative incidence of pertussis in an unvaccinated preschool cohort based on notifications, interview and serology. Eur J Epidemiol 1991, 7(2):121-126.
26. Kelly H., Riddell M.A., Gidding H.F., Nolan T., Gilbert G.L. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002, 20(25-26):3130-3136.